Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for children with rare fatal brain disease: drug safety tracked

NCT ID NCT04476862

First seen Jan 15, 2026 · Last updated May 21, 2026 · Updated 22 times

Summary

This study tracks the long-term safety of cerliponase alfa in 35 children with CLN2 disease, a rare and fatal genetic disorder that causes seizures, loss of movement, and speech. Participants are already receiving or will start the treatment. Researchers monitor for serious side effects and how the drug affects motor and language skills over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Advent Health

    Orlando, Florida, 32803, United States

  • Arkansas Children's Hospital

    Little Rock, Arkansas, 72205, United States

  • Boston Children's Hospital,

    Boston, Massachusetts, 02115, United States

  • Children's Healthcare of Atlanta

    Atlanta, Georgia, 30329, United States

  • Children's Hospital Minnesota

    Minneapolis, Minnesota, 55404, United States

  • Children's Hospital of Colorado

    Aurora, Colorado, 80045, United States

  • Children's Hospital of Orange County

    Orange, California, 92868, United States

  • Children's National Hospital

    Washington D.C., District of Columbia, 20010, United States

  • Mt. Sinai School of Medicine

    New York, New York, 10029, United States

  • NYU Langone Medical Center

    New York, New York, 10017, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, 43130, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98145-5005, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104, United States

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.